James A. Duce

6.9k total citations · 2 hit papers
62 papers, 4.4k citations indexed

About

James A. Duce is a scholar working on Physiology, Neurology and Nutrition and Dietetics. According to data from OpenAlex, James A. Duce has authored 62 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 22 papers in Neurology and 18 papers in Nutrition and Dietetics. Recurrent topics in James A. Duce's work include Alzheimer's disease research and treatments (27 papers), Parkinson's Disease Mechanisms and Treatments (17 papers) and Trace Elements in Health (16 papers). James A. Duce is often cited by papers focused on Alzheimer's disease research and treatments (27 papers), Parkinson's Disease Mechanisms and Treatments (17 papers) and Trace Elements in Health (16 papers). James A. Duce collaborates with scholars based in Australia, United Kingdom and France. James A. Duce's co-authors include Ashley I. Bush, Bruce X. Wong, Scott Ayton, David Devos, Paul A. Adlard, Colin L. Masters, Jean-Christophe Devedjian, Robert A. Cherny, Blaine R. Roberts and Laura Mahoney‐Sanchez and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Neuroscience.

In The Last Decade

James A. Duce

62 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

2012 472 citations Peng Lei, Scott Ayton et al. profile →
Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

2020 367 citations Laura Mahoney‐Sanchez, Scott Ayton et al. profile →

Peers

Countries citing papers authored by James A. Duce

Since Specialization

Citations

This map shows the geographic impact of James A. Duce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Duce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Duce more than expected).

Fields of papers citing papers by James A. Duce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Duce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Duce. The network helps show where James A. Duce may publish in the future.

Co-authorship network of co-authors of James A. Duce

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Duce. A scholar is included among the top collaborators of James A. Duce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Duce. James A. Duce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons 2022 ·Free Radical Biology and Medicine ·(unknown), Laura Mahoney‐Sanchez, Guillaume Garçon, Olivier Berdeaux, L. Alleman, David Devos, James A. Duce, Jean-Christophe Devedjian	74
2	The acute phase protein lactoferrin is a key feature of Alzheimer’s disease and predictor of Aβ burden through induction of APP amyloidogenic processing 2021 ·Molecular Psychiatry ·Andrew Tsatsanis, (unknown), Bruce X. Wong, Ellis Patrick, Tim Ryan, Robert W. Evans, Ashley I. Bush, Greg T. Sutherland, Asipu Sivaprasadarao, Boris Guennewig, James A. Duce	36
3	Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get 2020 ·Journal of Neurochemistry ·(unknown), (unknown), M P Jackson, (unknown), James A. Duce, Hilal A. Lashuel	19
4	Author Correction: A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis 2020 ·Scientific Reports ·David Devos, Caroline Moreau, Maéva Kyheng, Guillaume Garçon, Anne‐Sophie Rolland, Hélène Blasco, Patrick Gelé, Timothée Lenglet, Charlotte Veyrat‐Durebex, Philippe Corcia, Mary Dutheil, Peter Bede, Andreas Jeromin, Patrick Oeckl, Markus Otto, Vincent Meininger, Véronique Danel-Brunaud, Jean-Christophe Devedjian, James A. Duce, Pierre Pradat	2
5	Increased glutaminyl cyclase activity in brains of Alzheimer’s disease individuals 2020 ·Journal of Neurochemistry ·Adam P. Gunn, Bruce X. Wong, Catriona McLean, Christopher Fowler, Peter J. Barnard, James A. Duce, Blaine R. Roberts	17
6	Amyloid Precursor Protein Mediates Neuronal Protection from Rotenone Toxicity 2019 ·Molecular Neurobiology ·(unknown), Hayley S. Waugh, Vicki Chrysostomou, M. Isabel G. Lopez Sanchez, (unknown), Mark Cook, Jonathan G. Crowston, Andrew F. Hill, James A. Duce, Ashley I. Bush, Ian A. Trounce	10
7	Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model 2019 ·Disease Models & Mechanisms ·(unknown), Christine L. Le Maitre, James A. Duce, Caroline Dalton, David P. Smith	33
8	A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis 2019 ·Scientific Reports ·David Devos, Caroline Moreau, Maéva Kyheng, Guillaume Garçon, Anne‐Sophie Rolland, Hélène Blasco, Patrick Gelé, Timothée Lenglet, Charlotte Veyrat‐Durebex, Philippe Corcia, Mary Dutheil, Peter Bede, Andreas Jeromin, Patrick Oeckl, Markus Otto, Vincent Meininger, Véronique Danel-Brunaud, Jean-Christophe Devedjian, James A. Duce, Pierre Pradat	114
9	Iron as a therapeutic target for Parkinson's disease 2018 ·Movement Disorders ·Caroline Moreau, James A. Duce, Olivier Rascol, Jean‐Christophe Devedjian, Daniela Berg, David T. Dexter, (unknown), Ashley I. Bush, David Devos, (unknown)	101
10	Cortical biometals: Changed levels in suicide and with mood disorders 2018 ·Journal of Affective Disorders ·Brian Dean, Linh Q. Lam, Elizabeth Scarr, James A. Duce	10
11	Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice 2018 ·Neurotherapeutics ·Abdel Ali Belaidi, Adam P. Gunn, Bruce X. Wong, Scott Ayton, Ambili T. Appukuttan, Blaine R. Roberts, James A. Duce, Ashley I. Bush	60
12	Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease? 2017 ·Neurobiology of Disease ·Charlotte Laloux, Flore Gouel, Cédrick Lachaud, Kelly Timmerman, (unknown), Aurélie Jonneaux, Maud Pétrault, Guillaume Garçon, Nathalie Rouaix, Caroline Moreau, Régis Bordet, James A. Duce, Jean-Christophe Devedjian, David Devos	17
13	Lithium suppression of tau induces brain iron accumulation and neurodegeneration 2016 ·Molecular Psychiatry ·Peng Lei, Scott Ayton, Ambili T. Appukuttan, (unknown), James A. Duce, Irene Volitakis, Robert A. Cherny, Stephen J. Wood, Mark Greenough, Gregor Berger, Christos Pantelis, Patrick D. McGorry, Alison R. Yung, David I. Finkelstein, Ashley I. Bush	73
14	The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders 2014 ·Frontiers in Pharmacology ·Bruce X. Wong, James A. Duce	38
15	Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine 2013 ·PLoS ONE ·Jianfang Chen, Eileen Marks, Barry Lai, Zhaojie Zhang, James A. Duce, Linh Q. Lam, Irene Volitakis, Ashley I. Bush, Steven M. Hersch, Jonathan H. Fox	144
16	Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levels 2012 ·Molecular Psychiatry ·James A. Duce, Scott Ayton, Alita A. Miller, Andrew Tsatsanis, Linh Q. Lam, Laura Leone, J. E. Corbin, Helmut Butzkueven, Trevor J. Kilpatrick, Jack T. Rogers, Kevin J. Barnham, David I. Finkelstein, Ashley I. Bush	12
17	The role of metallobiology and amyloid‐β peptides in Alzheimer’s disease 2011 ·Journal of Neurochemistry ·Blaine R. Roberts, Timothy J. Ryan, Ashley I. Bush, Colin L. Masters, James A. Duce	224
18	Elevated labile Cu is associated with oxidative pathology in Alzheimer disease 2011 ·Free Radical Biology and Medicine ·Simon James, Irene Volitakis, Paul A. Adlard, James A. Duce, Colin L. Masters, Robert A. Cherny, Ashley I. Bush	147
19	17β-Estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult 2007 ·Brain Research ·(unknown), (unknown), James A. Duce, David I. Finkelstein	27
20	Copper-Dependent Inhibition of Human CytochromecOxidase by a Dimeric Conformer of Amyloid-β_1-42 2005 ·Journal of Neuroscience ·Peter J. Crouch, Rachel Blake, James A. Duce, Giuseppe D. Ciccotosto, Qiao‐Xin Li, Kevin J. Barnham, Cyril C. Curtain, Robert A. Cherny, Roberto Cappai, Thomas Dyrks, Colin L. Masters, Ian A. Trounce	290

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact